Tower Research Capital LLC (Trc) Htg Molecular Diagnostics, Inc Transaction History

Tower Research Capital LLC (Trc)

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$0.62 - $1.89 $401 - $1,224	-648 Reduced 12.57%	4,508 $3,000
Q2 2022 Aug 15, 2022	BUY	$0.46 - $1.45 $1,789 - $5,641	3,891 Added 307.59%	5,156 $5,000
Q1 2022 May 12, 2022	BUY	$1.39 - $5.51 $1,758 - $6,970	1,265 New	1,265 $2,000
Q4 2021 Feb 14, 2022	SELL	$3.23 - $5.97 $6,450 - $11,922	-1,997 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$5.01 - $6.8 $10,004 - $13,579	1,997 New	1,997 $11,000
Q2 2021 Aug 16, 2021	SELL	$3.52 - $5.98 $38,265 - $65,008	-10,871 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$4.99 - $7.83 $1,492 - $2,341	299 Added 2.83%	10,871 $59,000
Q4 2020 Feb 16, 2021	BUY	$4.14 - $5.95 $43,768 - $62,903	10,572 New	10,572 $51,000

Ticker HTGM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 11,048,100
Market Cap $3.76M
Description
HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables comprising assay kits; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-o...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.